<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation-group" /><meta name="keywords" content="" /><title>Azathioprine formulations [unlicensed]: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP5607-azathioprine-formulations-unlicensed.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP5607-azathioprine-formulations-unlicensed.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP5607-azathioprine-formulations-unlicensed.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP5179-malignant-disease-and-immunosuppression.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="PHP5590-drugs-affecting-the-immune-response.htm">8.2 Drugs affecting the immune response</a> &gt; <a href="PHP5598-antiproliferative-immunosuppressants.htm">8.2.1 Antiproliferative immunosuppressants</a> &gt; <a href="PHP5601-azathioprine.htm">AZATHIOPRINE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP5598-antiproliferative-immunosuppressants.htm" title="Previous: 8.2.1 Antiproliferative immunosuppressants">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP5608-mycophenolate-mofetil.htm" title="Next: MYCOPHENOLATE MOFETIL">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382167.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Azathioprine, Azathioprine Sodium</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Immunosuppressive Agents 92:44</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/1812-l.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Azathioprine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: A &gt; Interactions of Azathioprine</p></div></li></ul><ul><li><h3>British National Formulary (12)</h3></li><li><a href="PHP479-inflammatory-bowel-disease.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Inflammatory bowel disease</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="PHP527-azathioprine.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">AZATHIOPRINE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders &gt; 1.5.3 Drugs affecting the immune response</p></div></li><li><a href="PHP5598-antiproliferative-immunosuppressants.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.2.1 Antiproliferative immunosuppressants</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22azathioprine%22%22azathioprine%22%22azathioprine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (12)</a></li></ul><ul><li><h3>BNF for Children (9)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11193-inflammatory-bowel-disease.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Inflammatory bowel disease</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11229-drugs-affecting-the-immune-response.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">1.5.3 Drugs affecting the immune response</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11230-azathioprine.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">AZATHIOPRINE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders &gt; 1.5.3 Drugs affecting the immune response</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22azathioprine%22%22azathioprine%22%22azathioprine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (9)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0147.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Azathioprine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; A</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a582015.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Azathioprine Sodium</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; A</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0001s0398.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Azathioprine</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; A</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/A25-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Azathioprine</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; A</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1812-l.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Azathioprine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Immunosuppressants &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/00902.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Azathioprine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; A &gt; AZ</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c113-sec1-003.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Practice Considerations</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 2: The Practice of Pharmacy &gt; Section 10: Patient Care &gt; 113 Pharmacogenomics in Pharmacy Practice</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-A139.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Azathioprine</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; A</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D113.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Azathioprine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; A</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c42.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Azathioprine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; A</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>AZATHIOPRINE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int519-azathioprine.htm">Azathioprine</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">see <a title="target-block: Azathioprine" href="PHP5598-antiproliferative-immunosuppressants.htm#PHP5599">notes above</a>; inflammatory bowel disease [unlicensed indication] (<a title="BNF:monograph: AZATHIOPRINE" href="PHP527-azathioprine.htm">section 1.5.3</a>); rheumatoid arthritis (<a title="monograph-family: Drugs affecting the immune response" href="PHP6590-drugs-affecting-the-immune-response.htm">section 10.1.3</a>); severe refractory eczema [unlicensed indication] (<a title="BNF:monograph: AZATHIOPRINE" href="PHP7770-azathioprine.htm">section 13.5.3</a>)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="BNF:target-block: Immunosuppressant bioavailability" href="PHP5591-immunosuppressant-therapy.htm#PHP5592">Bioavailability</a>; thiopurine methyltransferase status (see notes above); monitor for toxicity throughout treatment; monitor full blood count weekly (more frequently with higher doses or if severe hepatic or renal impairment) for first 4 weeks (manufacturer advises weekly monitoring for 8 weeks but evidence of practical value unsatisfactory), thereafter reduce frequency of monitoring to at least every 3 months; reduce dose in elderly; <strong>interactions:</strong> Appendix 1 (azathioprine)</p></div> <div id="PHP5603" class="cG"><div class="cE"><h3 class="cT">Bone marrow suppression</h3> <p class="cT">Patients should be warned to report immediately any signs or symptoms of bone marrow suppression e.g. inexplicable bruising or bleeding, infection</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">see notes above; hypersensitivity to mercaptopurine</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">reduce dose; monitor liver function; see also Cautions</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">reduce dose; see also Cautions</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">treatment should not generally be initiated during pregnancy; see also <a title="BNF:target-block: pregnancy immunosuppressant" href="PHP5591-immunosuppressant-therapy.htm#PHP5593">Immunosuppressant therapy</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">present in milk in low concentration; no evidence of harm in small studies—use if potential benefit outweighs risk</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">hypersensitivity reactions (including malaise, dizziness, vomiting, diarrhoea, fever, rigors, myalgia, arthralgia, rash, hypotension and interstitial nephritis—calling for immediate withdrawal); dose-related bone marrow suppression (see also Cautions); liver impairment, cholestatic jaundice, hair loss and increased susceptibility to infections and colitis in patients also receiving corticosteroids; nausea; <em>rarely</em> pancreatitis, pneumonitis, hepatic veno-occlusive disease, lymphoma, red cell aplasia—see <a title="BNF:target-block: Mycophenolate" href="PHP5598-antiproliferative-immunosuppressants.htm#PHP5600">notes above</a></p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul> <li><p><span class="cK">By mouth</span>,<em> or </em>(if oral administration not possible—intravenous solution very irritant, see below) <span class="cK">by intravenous injection</span> over at least 1 minute (followed by 50 mL sodium chloride intravenous infusion), <em>or </em><span class="cK">by intravenous infusion</span> </p> <p>Autoimmune conditions, 1–3 mg/kg daily, adjusted according to response (consider withdrawal if no improvement within 3 months)</p> <p>Suppression of transplant rejection, 1–2.5 mg/kg daily adjusted according to response</p> </li>   </ul><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Azathioprine doses in BNF may differ from those in product literature</p></div></div><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Intravenous injection is alkaline and very irritant, intravenous route should therefore be used <strong>only</strong> if oral route not feasible, see also Appendix 4</p></div></div></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP5605-azathioprine-non-proprietary.htm#PHP5605-azathioprine-non-proprietary" title="Azathioprine">Azathioprine</a></li><li><a href="PHP5606-imuran.htm#PHP5606-imuran" title="Imuran®">Imuran®</a></li></ul><div id="PHP5607-azathioprine-formulations-unlicensed" style="margin: 0 0 0 20px;"><h1 class="title">Azathioprine formulations [unlicensed]</h1><p>Available from <a title="appendix: Special-order Manufacturers" href="PHP10403-special-order-manufacturers.htm">‘special-order’ manufacturers or specialist importing companies</a></p></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP5598-antiproliferative-immunosuppressants.htm">Previous: 8.2.1 Antiproliferative immunosuppressants</a> | <a class="top" href="PHP5607-azathioprine-formulations-unlicensed.htm#">Top</a> | <a accesskey="]" href="PHP5608-mycophenolate-mofetil.htm">Next: MYCOPHENOLATE MOFETIL</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>